Quest for Growth Belgium
Sector
Location
Market Cap
USD 92.21 M
Share Price
USD 4.93
Avg Daily Volume
10,026
Change (1 day)
Change (1 year)
Change (YTD)
Investor AB (publ)
USD 30.06
INVE-B.ST
Royalty Pharma plc
USD 35.86
RPRX
SBI Holdings, Inc.
USD 44.26
8473.T
BB Biotech AG
USD 38.65
BION.SW
Eli Lilly and Company
USD 639.43
LLY
AbbVie Inc.
USD 198.64
ABBV
Roche Holding AG
USD 320.12
RO.SW
AstraZeneca PLC
USD 150.15
AZN.L
Abbott Laboratories
USD 131.02
ABT
Novartis AG
USD 119.03
NOVN.SW
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
Merck & Co., Inc.
USD 80.30
MRK
Thermo Fisher Scientific Inc.
USD 477.41
TMO
Amgen Inc.
USD 284.98
AMGN
Gilead Sciences, Inc.
USD 120.02
GILD
Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
---|
Investor AB (publ)
USD 30.06
INVE-B.ST
Royalty Pharma plc
USD 35.86
RPRX
SBI Holdings, Inc.
USD 44.26
8473.T
BB Biotech AG
USD 38.65
BION.SW
Eli Lilly and Company
USD 639.43
LLY
AbbVie Inc.
USD 198.64
ABBV
Roche Holding AG
USD 320.12
RO.SW
AstraZeneca PLC
USD 150.15
AZN.L
Abbott Laboratories
USD 131.02
ABT
Novartis AG
USD 119.03
NOVN.SW
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
Merck & Co., Inc.
USD 80.30
MRK
Thermo Fisher Scientific Inc.
USD 477.41
TMO
Amgen Inc.
USD 284.98
AMGN
Gilead Sciences, Inc.
USD 120.02
GILD